EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotic Adjuvant Potential of Selected Essential Oil Components Against Respiratory Pathogens: From Planktonic Synergy to Early-Stage Biofilm Inhibition

Viktória Lilla Balázs, Rita Filep, Edit Ormai iD, Lilla Radványi, Béla Kocsis, Erika Kerekes, Marianna Kocsis iD

Antibiotics · 16.04.2026 · 15 (4) · 403

DOI: 10.3390/antibiotics15040403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 16.04.2026. Verfasst von Viktória Lilla Balázs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, Development and Innovation Office, Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Office.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory tract infections remain among the most common indications for antibiotic therapy and represent a major driver of antimicrobial resistance. The ability of respiratory pathogens to form biofilms further contributes to treatment failure and recurrence. This study aimed to evaluate the antibiotic adjuvant potential of selected essential oil components against clinically relevant respiratory bacteria and to determine whether planktonic synergistic interactions translate into early-stage antibiofilm efficacy. Thymol, eugenol, trans-cinnamaldehyde, and terpinen-4-ol were tested against Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa.

Methods

Minimum inhibitory concentrations were determined by broth microdilution. Synergistic interactions with clinically relevant antibiotics were assessed using the checkerboard method and fractional inhibitory concentration index (FICI) analysis. Selected combinations were further evaluated in a 6 h crystal violet-based early-stage biofilm model. Gram-positive strains generally exhibited higher susceptibility to the tested components than Gram-negative bacteria.

Results

Synergistic interactions (FICI ≤ 0.5) were most frequently observed between β-lactam antibiotics and phenolic components, particularly thymol and trans-cinnamaldehyde. Strong synergy was detected for vancomycin-eugenol against MRSA and for amoxicillin/clavulanic acid–cinnamaldehyde against M. catarrhalis. Importantly, synergistic combinations translated into significantly enhanced inhibition of early biofilm formation, increasing inhibition rates by 15–40% compared to antibiotic monotherapy (p < 0.05). Selected essential oil components enhanced the antibacterial activity of clinically relevant antibiotics and effectively potentiated early-stage biofilm inhibition.

Conclusions

These findings support further investigation of phytochemical-antibiotic combinations as potential adjunct strategies in respiratory infection management.

Schlagwörter

Stichwörter der Autor:innen

antibiotic adjuvantsbiofilmessential oil componentsrespiratory pathogens

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary.
  • Department of Medical Microbiology, Medical School, University of Pécs, 7624 Pécs, Hungary.
  • Department of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, 6726 Szeged, Hungary.
  • Department of Agricultural Biology, Institute of Biology, University of Pécs, 7624 Pécs, Hungary.

ORCID-Profile: Edit Ormai, Marianna Kocsis

Förderung

  • National Research, Development and Innovation Office
  • Development and Innovation Office
  • Ministry of Culture and Innovation of Hungary from the National Research, Development and Innovation Office

Zitieren

APA

Balázs, V. L., Filep, R., Ormai, E., Radványi, L., Kocsis, B., Kerekes, E., & Kocsis, M. (2026). Antibiotic Adjuvant Potential of Selected Essential Oil Components Against Respiratory Pathogens: From Planktonic Synergy to Early-Stage Biofilm Inhibition. Antibiotics, 15(4), 403. https://doi.org/10.3390/antibiotics15040403

Vancouver

Balázs VL, Filep R, Ormai E, Radványi L, Kocsis B, Kerekes E, et al. Antibiotic Adjuvant Potential of Selected Essential Oil Components Against Respiratory Pathogens: From Planktonic Synergy to Early-Stage Biofilm Inhibition. Antibiotics. 2026;15(4):403. doi:10.3390/antibiotics15040403

BibTeX
@article{Balzs2026,
  author = {Balázs, Viktória Lilla and Filep, Rita and Ormai, Edit and Radványi, Lilla and Kocsis, Béla and Kerekes, Erika and Kocsis, Marianna},
  title = {Antibiotic Adjuvant Potential of Selected Essential Oil Components Against Respiratory Pathogens: From Planktonic Synergy to Early-Stage Biofilm Inhibition},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {403},
  doi = {10.3390/antibiotics15040403}
}
Kostenlos starten →